EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

User Photo
Cancer-News

9 months
62 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Andrew Krivoshik, MD of @AstellasUS explains insights on EV-103 enfortumab vedotin plus pembrolizumab that was presented at ESMO. #ESMO2019
Up Next Autoplay